The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss

NCT05403229 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Sudden Deafness
Sudden Sensorineural Hearing Loss

Interventions

DRUG: Topiramate
DRUG: Systemic Steroids

Sponsor

Chang Gung Memorial Hospital